CLINICAL_TRIALS
trial_result
· 2011-01-24
Clinical Trial Update: Phase IIIB Subcutaneous Abatacept Monotherapy Study [Phase 3]
Summary
A Phase III trial of subcutaneous abatacept monotherapy in rheumatoid arthritis completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis (RA) | Phase 3 | Status: COMPLETED | Results posted: 2011-01-24